Clinical Trials Logo

Feasibility clinical trials

View clinical trials related to Feasibility.

Filter by:

NCT ID: NCT03556878 Completed - Sleep Disorder Clinical Trials

Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment

Start date: July 20, 2018
Phase: N/A
Study type: Interventional

The goal is to collect pilot data on an adapted version of the Transdiagnostic Sleep and Circadian intervention (TranS-C), referred to as 'Fitted TranS-C'.

NCT ID: NCT03532048 Completed - Feasibility Clinical Trials

Feasibility of Healthy Dads Healthy Kids Latino

Start date: August 11, 2018
Phase: N/A
Study type: Interventional

This is a feasibility study of a culturally adapted version of Healthy Dads Healthy Kids for Hispanic families. The adapted version called Papás Saludables, Niños Saludables is a father-targeted program for child obesity prevention and weight loss for fathers. The feasibility study will be conducted with 40 Hispanic families. Baseline assessments (T0) will be completed on all participating family members, followed by randomization to start the program immediately (intervention group), or 6-7 months later (wait-list control). Post assessments (T1) will be completed on the full sample once the intervention group has participated in the 10 week Papás Saludables, Niños Saludables program. A process evaluation will be conducted to assess the feasibility outcomes of the study.

NCT ID: NCT03503968 Terminated - Safety Clinical Trials

TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms

Start date: March 27, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicentre, non-randomized, open-label, Phase I/II clinical trial of MDG1011, an investigational medicinal product (IMP), consisting of patient-derived autologous T cells, persistently transduced with a Preferentially Expressed Antigen in Melanoma (PRAME)-specific human leukocyte antigen (HLA)-A*02:01-restricted T cell receptor (TCR).

NCT ID: NCT03390946 Not yet recruiting - Osteosarcoma Clinical Trials

Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma

Start date: February 1, 2018
Phase: Phase 2
Study type: Interventional

The aim of the study is to test the feasibility of four-drug, interval-compressed regimen in osteosarcoma. Primary objective is to explore the toxicity and mortality related to treatment. Secondary objectives are to examine tumor necrosis rates after neoadjuvant chemotherapy, and to evaluate the usefulness of circulating cell-free DNA, survivin, or transforming growth factor-beta1 levels as well as programmed cell death ligand 1 expression in tumor specimen as a predictive or prognostic biomarker in osteosarcoma patients.

NCT ID: NCT03318068 Completed - Quality of Life Clinical Trials

Outpatient Yoga Study for Adolescents Receiving Chemotherapy

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

LAY SUMMARY: The diagnosis and treatment of pediatric cancer is a significant stressor for adolescents and their families . Although most adolescents cope well with their cancer diagnosis, many experience emotional distress. A small proportion of those diagnosed with cancer will experience more intense mental distress, such as depression, anxiety, or anger. The practice of yoga may be a possible way of treating the negative emotional symptoms experienced by these adolescents. Previous studies suggest that yoga may improve anxiety, mood and psychological distress in adults with cancer. The results of two recent pediatric pilot studies show that yoga programs improved quality of life for adolescents receiving cancer treatment. Given this, we wish to examine the feasibility of offering a 10-week yoga program for adolescents who are receiving outpatient chemotherapy. This program includes both one-on-one in-person sessions and home-based sessions offered using SkypeTM. To assess this program, we will monitor patients' attendance, ask their opinions of the program and evaluate whether yoga improved their mental well-being. This study represents an important step toward identifying possible treatments to improve patients' quality of life and emotional health.

NCT ID: NCT03286192 Completed - Feasibility Clinical Trials

Compassion Cultivation Training for Nurses

Start date: September 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility of implementing a Compassion Cultivation Training (CCT) program for oncology nurses at Sylvester Comprehensive Cancer Center. The goal of CCT is to provide a structured and systematic way of cultivating daily-life skills needed to strengthen qualities of compassion, empathy, and kindness for oneself and others. CCT typically includes (i) eight weekly 2-hour classes and (ii) daily practice. The in-class activities include pedagogical instruction and active group discussion, guided meditation, interactive practical exercises, and sharing of inspiring readings/stories to prime feelings of open-heartedness or connection to others.

NCT ID: NCT03237871 Completed - Feasibility Clinical Trials

The EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults

Start date: July 7, 2017
Phase: N/A
Study type: Interventional

As part of the development of the Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) Project, the study team will conduct a single-group study to examine the feasibility of assessing economic and sexual risk behaviors using text messages. The team will enroll approximately 20 young adults, aged 18 to 24, who are African-American, homeless, out-of-school, and un/under-employed. Participants will complete a text-messaged survey each week for 5 weeks. The study team will collect information about the number of participants who respond to the weekly survey, the number of questions to which they respond in each survey, and the number of hours from sending a survey to participants to receiving their response. As an exploratory aim, participants will also receive 3 informational text messages each week for 5 weeks on HIV prevention and economic empowerment. The study team will obtain qualitative feedback from participants regarding text messages they most and least liked. The survey is not designed to evaluate the effectiveness of the text message intervention.

NCT ID: NCT03120091 Completed - Safety Clinical Trials

Assessment of the Accuracy,Feasibility,Safety of Continuous Glucose Monitoring System

Start date: July 1, 2014
Phase: N/A
Study type: Observational

Real-time continuous glucose monitoring system (CGMS) has been attempted to be used in ICU, but its feasibility, accuracy and confounding factors are controversial.

NCT ID: NCT03012919 Completed - Feasibility Clinical Trials

Evaluation of an Active Decision Support System for Hemodynamic Optimization During High Risk Vascular Surgery

Start date: February 2015
Phase: N/A
Study type: Interventional

Rivers et al. laid the foundation for modern hemodynamic and fluid management by establishing goal directed therapy (GDT) for the treatment of sepsis using fluid and inotropic and vasoactive agents. There have been many subsequent protocols to improve outcome in the operating room or in the ICU. These are mainly passive decision support systems. Active clinical decision support systems using fluid and pharmacologic agents to improve intraoperative hemodynamics are not really found. The investigators developed an active clinical decision support system based on an institutional GDT-protocol using fluid, vasopressors and inotropes using the LiDCOrapid device. The goal of the study was to check the feasibility of an active clinical decision support system to optimize hemodynamics during high risk vascular surgery based on the principles of GDT implementing fluid, vasopressors and inotropes.

NCT ID: NCT02725073 Recruiting - Feasibility Clinical Trials

Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma

PDT
Start date: January 2016
Phase: Phase 2
Study type: Interventional

To determine the safety and efficacy of photodynamic therapy with a novel photosensitizer and a flexible laser probe in locally advanced hilar cholangiocarcinoma.